BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36254085)

  • 1. Mac-2-binding protein glycosylation isomer is useful to predict muscle cramps in patients with chronic liver disease.
    Miwa T; Hanai T; Sakai Y; Kochi T; Katsumura N; Shimizu M
    Medicine (Baltimore); 2022 Oct; 101(41):e31145. PubMed ID: 36254085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical usefulness of Mac-2 binding protein glycosylation isomer for diagnosing liver cirrhosis and significant fibrosis in patients with chronic liver disease: A retrospective single-center study.
    Park HJ; Seo KI; Lee SU; Han BH; Yun BC; Park ET; Lee J; Hwang H; Yoon M
    Medicine (Baltimore); 2022 Oct; 101(40):e30489. PubMed ID: 36221351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients.
    Mak LY; To WP; Wong DK; Fung J; Liu F; Seto WK; Lai CL; Yuen MF
    World J Gastroenterol; 2019 Mar; 25(11):1398-1408. PubMed ID: 30918432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of Mac-2 binding protein glycosylation isomer (M2BPGi) in screening liver fibrosis in health checkups.
    Nah EH; Cho S; Kim S; Kim HS; Cho HI
    J Clin Lab Anal; 2020 Aug; 34(8):e23316. PubMed ID: 32227396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of Mac-2-binding protein glycosylation isomer (M2BPGi) as a liver fibrosis marker in chronic hepatitis C patients with chronic kidney disease on hemodialysis.
    Sulaiman AS; Hasan I; Hustrini NM; Lydia A; Hanifa RS; Gani RA
    Clin Exp Nephrol; 2023 Jun; 27(6):557-564. PubMed ID: 36995542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of Mac-2-binding protein glycosylation isomer as a biomarker for albumin-bilirubin grade and the Controlling Nutritional Status score in chronic liver disease: investigation of cut-off values by the type of chronic liver disease.
    Ishikawa T; Kodama E; Kobayashi T; Azumi M; Nozawa Y; Iwanaga A; Sano T; Honma T
    Ann Palliat Med; 2022 Aug; 11(8):2658-2667. PubMed ID: 35815452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mac-2-Binding Protein Glycosylation Isomer to Albumin Ratio Predicts Bacterial Infections in Cirrhotic Patients.
    Wu PS; Hsieh YC; Lee PC; Yang TC; Chen YJ; Yang YY; Huang HC; Hsu SJ; Huo TI; Lee KC; Lin HC; Hou MC
    Dig Dis; 2024; 42(2):166-177. PubMed ID: 38219719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection.
    Mak LY; Wong DK; Seto WK; Ning Q; Cheung KS; Fung J; Lai CL; Yuen MF
    Hepatol Int; 2019 Mar; 13(2):148-156. PubMed ID: 30671807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Mac-2-binding protein glycosylation isomer level with nutritional status in chronic liver disease.
    Eso Y; Takai A; Taura K; Takahashi K; Ueda Y; Marusawa H; Seno H
    J Gastroenterol Hepatol; 2018 Feb; ():. PubMed ID: 29473206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients.
    Sulaiman AS; Hasan I; Lesmana CRA; Kurniawan J; Jasirwan COM; Nababan S; Kalista KF; Hanifa RS; Rachmani D; Gani RA
    Acta Med Indones; 2022 Oct; 54(4):567-573. PubMed ID: 36624717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of liver fibrosis with serum Mac-2 binding protein glycosylation-modified isomer (M2BPGi) during follow-up intestinal failure patients without intestinal failure-associated liver disease (IFALD).
    Ueno T; Takase K; Deguchi K; Masahata K; Nomura M; Watanabe M; Kamiyama M; Tazuke Y; Bessho K; Okuyama H
    Pediatr Surg Int; 2022 Dec; 38(12):1807-1813. PubMed ID: 36125546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Mac-2 binding protein glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation.
    Yamada N; Katano T; Hirata Y; Okada N; Sanada Y; Ihara Y; Urahashi T; Ushijima K; Karasawa T; Takahashi M; Mizuta K
    J Gastroenterol Hepatol; 2019 Feb; 34(2):418-424. PubMed ID: 30101431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C.
    Xu H; Kong W; Liu L; Chi X; Wang X; Wu R; Gao X; Wang H; Qu L; Qi Y; Pan Y; Niu J
    BMC Gastroenterol; 2017 May; 17(1):62. PubMed ID: 28486931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.
    Mak LY; Ko M; To E; Wong DK; Ma JH; Hui TL; Seto WK; Fung J; Lai CL; Yuen MF
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1817-1823. PubMed ID: 30786068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Serum Mac-2-binding Protein Glycosylation Isomer Dynamics in Acute Liver Injury.
    Seike T; Komura T; Shimizu Y; Omura H; Kumai T; Kagaya T; Ohta H; Kawashima A; Harada K; Kaneko S; Unoura M
    Intern Med; 2020 Jul; 59(13):1581-1588. PubMed ID: 32269188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis.
    Su TH; Peng CY; Tseng TC; Yang HC; Liu CJ; Liu CH; Chen PJ; Chen DS; Kao JH
    J Infect Dis; 2020 Feb; 221(4):589-597. PubMed ID: 31574141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of Mac-2 Binding Protein Glycosylation Isomer for Prediction of Posthepatectomy Liver Failure in Patients With Hepatocellular Carcinoma.
    Okuda Y; Taura K; Yoshino K; Ikeno Y; Nishio T; Yamamoto G; Tanabe K; Koyama Y; Hatano E; Tanaka S; Uemoto S
    Ann Surg; 2017 Jun; 265(6):1201-1208. PubMed ID: 27355265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection.
    Mak LY; Wong DK; Cheung KS; Seto WK; Lai CL; Yuen MF
    Clin Transl Gastroenterol; 2018 Jun; 9(6):163. PubMed ID: 29915243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia.
    Yamada N; Sanada Y; Tashiro M; Hirata Y; Okada N; Ihara Y; Urahashi T; Mizuta K
    J Gastroenterol; 2017 Feb; 52(2):245-252. PubMed ID: 27349650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Mac-2 Binding Protein Glycosylation Isomer Concentrations Are Associated With Incidence of Type 2 Diabetes.
    Higashioka M; Hirakawa Y; Hata J; Honda T; Sakata S; Shibata M; Kitazono T; Osawa H; Ninomiya T
    J Clin Endocrinol Metab; 2023 Jun; 108(7):e425-e433. PubMed ID: 36638007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.